Clinical Trials · NCT00782418
A Study to Compare Methodologies for Assessing Glucose-Dependent Insulin Secretion (0000-104)(COMPLETED)
- Phase
- Phase 1
- Recruitment status
- Completed
- Sponsor
- Merck Sharp & Dohme LLC
- Enrollment
- 27
- Start date
- Sep 2008
- Locations
- See registry
- Primary endpoint
- Change From Baseline in Insulin Secretion Rate (ISR) Normalized to Ambient Plasma Glucose